XBiotech, Inc. (XBIT)
2.18
+0.03
(+1.40%)
USD |
NASDAQ |
Sep 29, 16:00
2.17
-0.01
(-0.46%)
Pre-Market: 20:00
XBiotech Market Cap : 66.46M for Sept. 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 29, 2026 | 66.46M |
| September 28, 2026 | 65.55M |
| September 25, 2026 | 66.16M |
| September 24, 2026 | 65.85M |
| September 23, 2026 | 66.46M |
| September 22, 2026 | 66.46M |
| September 21, 2026 | 66.46M |
| September 18, 2026 | 66.77M |
| September 17, 2026 | 66.46M |
| September 16, 2026 | 65.55M |
| September 15, 2026 | 66.92M |
| September 14, 2026 | 66.16M |
| September 11, 2026 | 66.77M |
| September 10, 2026 | 66.16M |
| September 09, 2026 | 66.46M |
| September 08, 2026 | 66.46M |
| September 04, 2026 | 67.07M |
| September 03, 2026 | 67.07M |
| September 02, 2026 | 66.77M |
| September 01, 2026 | 67.68M |
| August 31, 2026 | 70.12M |
| August 28, 2026 | 69.21M |
| August 27, 2026 | 70.12M |
| August 26, 2026 | 70.43M |
| August 25, 2026 | 70.12M |
| Date | Value |
|---|---|
| August 24, 2026 | 70.43M |
| August 21, 2026 | 69.51M |
| August 20, 2026 | 70.43M |
| August 19, 2026 | 70.43M |
| August 18, 2026 | 69.21M |
| August 17, 2026 | 70.43M |
| August 14, 2026 | 70.12M |
| August 13, 2026 | 71.04M |
| August 12, 2026 | 75.00M |
| August 11, 2026 | 71.04M |
| August 10, 2026 | 69.51M |
| August 07, 2026 | 69.21M |
| August 06, 2026 | 69.51M |
| August 05, 2026 | 68.90M |
| August 04, 2026 | 68.29M |
| August 03, 2026 | 68.14M |
| July 31, 2026 | 67.99M |
| July 30, 2026 | 68.29M |
| July 29, 2026 | 68.60M |
| July 28, 2026 | 69.21M |
| July 27, 2026 | 68.90M |
| July 24, 2026 | 69.21M |
| July 23, 2026 | 69.51M |
| July 22, 2026 | 69.21M |
| July 21, 2026 | 68.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.481B |
| Alnylam Pharmaceuticals, Inc. | 33.98B |
| Anika Therapeutics, Inc. | 266.92M |
| Savara, Inc. | 1.043B |
| Vericel Corp. | 2.078B |
Market Cap Related Metrics
| PEG Ratio | -0.0244 |
| Price to Book Value | 0.5174 |
| Price | 2.18 |
| Earnings Yield | -67.91% |
| PEGY Ratio | -0.0244 |